BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 2013017)

  • 1. Growth hormone, insulin-like growth factors, and the skeleton.
    Giustina A; Mazziotti G; Canalis E
    Endocr Rev; 2008 Aug; 29(5):535-59. PubMed ID: 18436706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parathyroid hormone levels in pubertal uremic adolescents treated with growth hormone.
    Picca S; Cappa M; Martinez C; Moges SI; Osborn J; Perfumo F; Ardissino G; Bonaudo R; Montini G; Rizzoni G
    Pediatr Nephrol; 2004 Jan; 19(1):71-6. PubMed ID: 14634859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diurnal rhythm in serum osteocalcin: relation with sleep, growth hormone, and PTH(1-84).
    Nielsen HK; Brixen K; Kassem M; Christensen SE; Mosekilde L
    Calcif Tissue Int; 1991 Dec; 49(6):373-7. PubMed ID: 1818760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The growth hormone cascade: progress and long-term results of growth hormone treatment in growth hormone deficiency.
    Grumbach MM; Bin-Abbas BS; Kaplan SL
    Horm Res; 1998; 49 Suppl 2():41-57. PubMed ID: 9730672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum osteocalcin and bone isoenzyme alkaline phosphatase in growth hormone-deficient patients: dose-response studies with biosynthetic human GH.
    Nielsen HK; Jørgensen JO; Brixen K; Christiansen JS
    Calcif Tissue Int; 1991 Feb; 48(2):82-7. PubMed ID: 2013017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum bone alkaline phosphatase isoenzyme levels in normal children and children with growth hormone (GH) deficiency: a potential marker for bone formation and response to GH therapy.
    Tobiume H; Kanzaki S; Hida S; Ono T; Moriwake T; Yamauchi S; Tanaka H; Seino Y
    J Clin Endocrinol Metab; 1997 Jul; 82(7):2056-61. PubMed ID: 9215272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Skeletal effects of two years of treatment with low physiological doses of recombinant human growth hormone (GH) in patients with adult-onset GH deficiency.
    Janssen YJ; Hamdy NA; Frölich M; Roelfsema F
    J Clin Endocrinol Metab; 1998 Jun; 83(6):2143-8. PubMed ID: 9626153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of 1,25-dihydroxyvitamin D3 and growth hormone therapy on serum osteocalcin levels in children with growth hormone deficiency.
    Antoniazzi F; Radetti G; Zamboni G; Gambaro G; Adami S; Tatò L
    Bone Miner; 1993 May; 21(2):151-6. PubMed ID: 8358252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Additional beneficial effects of alendronate in growth hormone (GH)-deficient adults with osteoporosis receiving long-term recombinant human GH replacement therapy: a randomized controlled trial.
    Biermasz NR; Hamdy NA; Janssen YJ; Roelfsema F
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3079-85. PubMed ID: 11443170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant human growth hormone replacement therapy and bone metabolism in children.
    Zamboni G; Antoniazzi F; Tatò L
    J Pediatr Endocrinol; 1993; 6(1):33-7. PubMed ID: 8374686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Some effects of human growth hormone on renal hemodynamics and on tubular phosphate transport in man.
    CORVILAIN J; ABRAMOW M; BERGANS A
    J Clin Invest; 1962 Jun; 41(6):1230-5. PubMed ID: 13881516
    [No Abstract]   [Full Text] [Related]  

  • 12. Constancy of somatomedin response to growth hormone treatment of hypopituitary dwarfism, and lack of correlation with growth rate.
    Rosenfeld RG; Kemp SF; Hintz RL
    J Clin Endocrinol Metab; 1981 Sep; 53(3):611-7. PubMed ID: 7021582
    [No Abstract]   [Full Text] [Related]  

  • 13. Radioimmunoassay for the vitamin K-dependent protein of bone and its discovery in plasma.
    Price PA; Nishimoto SK
    Proc Natl Acad Sci U S A; 1980 Apr; 77(4):2234-8. PubMed ID: 6966406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accurate measurements of the lower leg length and the ulnar length and its application in short term growth measurement.
    Valk IM; Chabloz AM; Smals AG; Kloppenborg PW; Cassorla FG; Schutte EA
    Growth; 1983; 47(1):53-66. PubMed ID: 6862263
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.